REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Inali Zona Franca S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Inali Zona Franca S.A.S. Profile Updated: November 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Inali Zona Franca S.A.S. is an enterprise in Colombia, with the main office in Puerto Tejada. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on July 28, 2012. From the latest financial highlights, Inali Zona Franca S.A.S. reported a net sales revenue drop of 28.16% in 2022. Its’ total assets recorded a negative growth of 40.6%. The enterprise’s net profit margin decreased by 9.53% in 2022.

Headquarters
Lote 17Fetapa Iv Parque Industrial del Cauca
Puerto Tejada; Cauca;

Contact Details: Purchase the Inali Zona Franca S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Inali Zona Franca S.A.S. report to view the information.
Incorporation Date:
July 28, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Inali Zona Franca S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-28.16%▼
Total operating revenue
-25.65%▼
Operating profit (EBIT)
-74.38%▼
EBITDA
-70.93%▼
Net Profit (Loss) for the Period
-89.94%▼
Total assets
-40.6%▼
Total equity
3.04%▲
Operating Profit Margin (ROS)
-10.02%▼
Net Profit Margin
-9.53%▼
Return on Equity (ROE)
-27.31%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo